2022 Annual Meeting | C1 - Non-motor Parkinson’s Disease Symptoms
Program Materials Program Evaluations
| 06:30 AM - 07:00 AM PDT | Speaker |
Walk-in Slides
|
| 07:00 AM - 07:30 AM PDT | Speaker |
Prodromal Non-motor Symptoms in Parkinson's Disease
Shyamal Mehta, MD, PhD, FAAN |
| 07:30 AM - 08:10 AM PDT | Speaker |
The Spectrum of Autonomic Dysfunction in PD
Yi-Han Lin, MD |
| 08:10 AM - 08:50 AM PDT | Speaker |
Neuropsychiatric Manifestations in PD
Holly A. Shill, MD, FAAN |
| 08:50 AM - 09:00 AM PDT | Q&A |
Questions and Answers
Holly A. Shill, MD, FAAN, Shyamal Mehta, MD, PhD, FAAN |
| Holly A. Shill, MD, FAAN | Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encora. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Movement Disorders Society. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guideline Central. |
| Shyamal Mehta, MD, PhD, FAAN | Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings. |
| Yi-Han Lin, MD | The institution of Dr. Lin has received research support from UniQure. The institution of Dr. Lin has received research support from CHDI. The institution of Dr. Lin has received research support from Prilenia Therapeutics. The institution of Dr. Lin has received research support from Boston Scientific. The institution of Dr. Lin has received research support from BIAL. The institution of Dr. Lin has received research support from Novartis. |